OS Therapies IncorporatedOSTXNYSE
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank80
3Y CAGR+567.6%
5Y CAGR+124.0%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+567.6%/yr
Annual compound
5Y CAGR
+124.0%/yr
Recent acceleration
Percentile
P80
Within normal range
vs 5Y Ago
56.4x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $239537.00 | +8516.4% |
| 2024 | $2780.00 | -34.1% |
| 2023 | $4220.00 | +424.2% |
| 2022 | $805.00 | -99.9% |
| 2021 | $1.16M | +27185.7% |
| 2020 | $4250.00 | - |